Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100

计划入组 12 人 · 首次发布于 2018 年 4 月 23 日

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

计划入组 682 人 · 首次发布于 2019 年 12 月 18 日

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

计划入组 60 人 · 首次发布于 2015 年 8 月 20 日

aldose reductase inhibitors (Kowa)

CD26 antigen inhibitors (America Stem Cell)

leukotriene D4 antagonists (Kowa/Leiden/Amsterdam Center)

Kowa Pharmaceuticals America, Inc.

United States

Kowa

TAKEDA PHARMACEUTICALS AMERICA, INC.

United States

Integrase Inhibitor HIV Regimens Linked to Higher Cardiometabolic Risks, REPRIEVE Study Reveals

FDA Grants Breakthrough Therapy Designation to Kowa's Pemafibrate (K-808) for Primary Biliary Cholangitis

Nicox Completes Key Data Generation for NCX 470 Glaucoma Drug, NDA Submission Planned for H1 2026